Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Little

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Clinical Biomechanics (Bristol, Avon)|November 26, 2002
Zoledronic acid improves the mechanical properties of normal and healing boneL E Bilston, D G Little, N C Smith, et al.
Injury|January 29, 2002
Effect of pamidronate on distraction osteogenesis and fixator-related osteoporosisD G Little, M S Cornell, M S Hile, et al.
The Journal of Bone and Joint Surgery. British Volume|October 18, 2001
Intravenous pamidronate reduces osteoporosis and improves formation of the regenerate during distraction osteogenesis. A study in immature rabbitsD G Little, M S Cornell, J Briody, et al.
Calcified Tissue International|June 27, 2018
Diagnosis of Recurrent Fracture in a Pediatric CohortM Fiscaletti, C P Coorey, A Biggin, et al.
Journal of Musculoskeletal & Neuronal Interactions|June 3, 2015
Skeletal muscle and motor deficits in Neurofibromatosis Type 1M A Summers, K G Quinlan, J M Payne, et al.
The Journal of Bone and Joint Surgery. British Volume|March 19, 2005
Zoledronic acid causes enhancement of bone growth into porous implantsJ D Bobyn, S A Hacking, J J Krygier, et al.
The Journal of Bone and Joint Surgery. British Volume|July 20, 2011
Distal tibial fracture repair in a neurofibromatosis type 1-deficient mouse treated with recombinant bone morphogenetic protein and a bisphosphonateA Schindeler, O Birke, N Y C Yu, et al.
European Cells & Materials|October 23, 2013
A sugar-based phase-transitioning delivery system for bone tissue engineeringT L Cheng, P Valtchev, C M Murphy, et al.
The Journal of Bone and Joint Surgery. American Volume|July 18, 2014
A Combination of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and MEK (MAP Kinase/ERK Kinase) Inhibitor PD0325901 Increases Bone Formation in a Murine Model of Neurofibromatosis Type I PseudarthrosisJ El-Hoss, T Cheng, E C Carpenter, et al.
Bone|December 3, 2014
Endochondral fracture healing with external fixation in the Sost knockout mouse results in earlier fibrocartilage callus removal and increased bone volume fraction and strengthA Morse, N Y C Yu, L Peacock, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Clinical Biomechanics (Bristol, Avon)|November 26, 2002
Zoledronic acid improves the mechanical properties of normal and healing boneL E Bilston, D G Little, N C Smith, et al.
Injury|January 29, 2002
Effect of pamidronate on distraction osteogenesis and fixator-related osteoporosisD G Little, M S Cornell, M S Hile, et al.
The Journal of Bone and Joint Surgery. British Volume|October 18, 2001
Intravenous pamidronate reduces osteoporosis and improves formation of the regenerate during distraction osteogenesis. A study in immature rabbitsD G Little, M S Cornell, J Briody, et al.
Calcified Tissue International|June 27, 2018
Diagnosis of Recurrent Fracture in a Pediatric CohortM Fiscaletti, C P Coorey, A Biggin, et al.
Journal of Musculoskeletal & Neuronal Interactions|June 3, 2015
Skeletal muscle and motor deficits in Neurofibromatosis Type 1M A Summers, K G Quinlan, J M Payne, et al.
The Journal of Bone and Joint Surgery. British Volume|March 19, 2005
Zoledronic acid causes enhancement of bone growth into porous implantsJ D Bobyn, S A Hacking, J J Krygier, et al.
The Journal of Bone and Joint Surgery. British Volume|July 20, 2011
Distal tibial fracture repair in a neurofibromatosis type 1-deficient mouse treated with recombinant bone morphogenetic protein and a bisphosphonateA Schindeler, O Birke, N Y C Yu, et al.
European Cells & Materials|October 23, 2013
A sugar-based phase-transitioning delivery system for bone tissue engineeringT L Cheng, P Valtchev, C M Murphy, et al.
The Journal of Bone and Joint Surgery. American Volume|July 18, 2014
A Combination of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and MEK (MAP Kinase/ERK Kinase) Inhibitor PD0325901 Increases Bone Formation in a Murine Model of Neurofibromatosis Type I PseudarthrosisJ El-Hoss, T Cheng, E C Carpenter, et al.
Bone|December 3, 2014
Endochondral fracture healing with external fixation in the Sost knockout mouse results in earlier fibrocartilage callus removal and increased bone volume fraction and strengthA Morse, N Y C Yu, L Peacock, et al.
Pageof 4